Blood glucose lowering efficacy of Avartaki Churna in Streptozotocin-induced Hyperglycemia in rats

Authors

  • Guruprasad C Nille Banaras Hindu University
  • Reddy K R C Banaras Hindu University
  • Anshuman Trigunayat

DOI:

https://doi.org/10.47552/ijam.v7i2.819

Keywords:

Avartaki Churna, Prameha, Streptozotocin

Abstract

Objective: To evaluate the hypoglycemic effect of Avartaki Churna (Cassia auriculata Linn.) in experimental animals. Materials and Methods: Avartaki Churna was prepared by the standard procedure of Churna Kalpana. Hyperglycemia was induced to create an equivalent to the diabetic state by giving streptozotocin (STZ) solution (intra-peritoneal [i.p.]) 35 mg/kg.  After assessment of hyperglycemia as an approximate induction of diabetes, Group IV animals were treated with 300 mg/kg of Avartaki Churna. For treatment comparison, Group III animals were treated with a standard hypoglycemic drug, glibenclamide 1 mg/kg. Blood sugar level was assessed by glucometer on the 7th, 14th, 21st  and 28th   day. Results: Avartaki Churna produced a significantly reduction of fasting blood glucose with various doses in STZ-induced diabetic rats. In a 4-week study, Avartaki Churna produced a significant reduction in blood glucose compared to glibenclamide. Conclusion: Avartaki Churna and glibenclamide significantly reduced blood sugar level. The results were more significant with successive days in this in vivo comparative study.

 

Author Biography

Anshuman Trigunayat

Department of Pharmacology, Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India

Downloads

Published

2016-06-25

How to Cite

Nille, G. C., R C, R. K., & Trigunayat, A. (2016). Blood glucose lowering efficacy of Avartaki Churna in Streptozotocin-induced Hyperglycemia in rats. International Journal of Ayurvedic Medicine, 7(2). https://doi.org/10.47552/ijam.v7i2.819

Issue

Vol. 7 No. 2 (2016): April - June 2016

Section

Research Articles

License

The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.

This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.

The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.

https://creativecommons.org/licenses/by-nc-sa/4.0/